Stock 301281 SHANDONG KEYUAN PHARMACEUTICAL CO., LTD.
Add to a list
To use this feature you must be a member
Log inSign up

Company Shandong Keyuan Pharmaceutical Co., Ltd.

Equities

301281

CNE1000061V8

Pharmaceuticals

End-of-day quote Shenzhen S.E.
Other stock markets
 23:00:00 20/06/2024 BST 		5-day change 1st Jan Change
24 CNY -1.72% Intraday chart for Shandong Keyuan Pharmaceutical Co., Ltd. +1.35% -29.49%
04-21 Shandong Keyuan Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
04-04 Certain A Shares of Shandong Keyuan Pharmaceutical Co., Ltd. are subject to a Lock-Up Agreement Ending on 4-APR-2024. CI

Business Summary

Shandong Keyuan Pharmaceutical Co Ltd is a China-based company mainly engaged in the research and development, production and sales of chemical APIs and their preparation products. The Company's main products include gliclazide, metformin hydrochloride, ropivacaine hydrochloride and others. The Company's products are used in hypoglycemic, anesthetic, cardiovascular and psychiatric diseases. The Company conducts its operations mainly in the domestic market.

Number of employees: 624

Sales per Business

CNY in Million2022Weight2023Weight Delta
Chemical Raw Materials
46.5 %
287 64.7 % 208 46.5 % -27.41%
Chemical Preparations
33.2 %
69 15.5 % 149 33.2 % +116.38%
Intermediates
19.9 %
87 19.6 % 89 19.9 % +2.49%
Other
0.4 %
1 0.1 % 2 0.4 % +197.68%

Sales per region

CNY in Million2022Weight2023Weight Delta
China
78.2 %
257 89.7 % 350 78.2 % +36.09%
Overseas
21.8 %
29 10.3 % 98 21.8 % +231.91%

Managers

Managers TitleAgeSince
Hong Sheng Jiang CEO
 Chief Executive Officer 50 15/05/23
Ji Lan Wang DFI
 Director of Finance/CFO 58 31/07/03
Li Jun Lun CHM
 Chairman 61 30/04/15
Guang Yong Sun CTO
 Chief Tech/Sci/R&D Officer 39 30/06/18
Zhao Wen Li BRD
 Director/Board Member 59 31/08/14
Gong Yuan Chang IRC
 Investor Relations Contact - -
Chuna Hua Li SEC
 Corporate Secretary 47 31/08/18
Li Feng AUD
 Comptroller/Controller/Auditor 52 31/08/15

Members of the board

Members of the board TitleAgeSince
Ying Ming Shen BRD
 Director/Board Member 65 22/04/19
Xiao Hong Zou BRD
 Director/Board Member 65 05/09/15
Hai Ying Zheng BRD
 Director/Board Member 61 22/04/19
Zhong Shan Zhang BRD
 Director/Board Member 62 31/08/14
Xiao Mei Zhao CHM
 Chairman 69 31/08/18
Li Jun Lun CHM
 Chairman 61 30/04/15
Yong Bo Ge BRD
 Director/Board Member 56 22/04/19
Zhao Wen Li BRD
 Director/Board Member 59 31/08/14
Kang Yuan BRD
 Director/Board Member 35 31/12/20
Hong Sheng Jiang CEO
 Chief Executive Officer 50 15/05/23

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 108,290,000 32,983,600 ( 30.46 %) 0 30.46 %

Shareholders

NameEquities%Valuation
Golden Trust Sinopac Fund Management Co., Ltd.
3.860 %
991,599 3.860 % 3 M ¥
Penghua Fund Management Co., Ltd.
0.1747 %
44,889 0.1747 % 157 644 ¥
Huatai-PineBridge Fund Management Co., Ltd.
0.0721 %
18,530 0.0721 % 65 075 ¥
Da Cheng Fund Management Co., Ltd.
0.0687 %
17,642 0.0687 % 61 956 ¥
HuaAn Fund Management Co., Ltd.
0.0533 %
13,683 0.0533 % 48 053 ¥
UBS SDIC Fund Management Co., Ltd.
0.0506 %
12,994 0.0506 % 45 633 ¥
Baoying Fund Management Co., Ltd.
0.0383 %
9,828 0.0383 % 34 515 ¥
Changsheng Fund Management Co., Ltd.
0.0358 %
9,195 0.0358 % 32 292 ¥
ICBC Credit Suisse Asset Management Co., Ltd.
0.0256 %
6,578 0.0256 % 23 101 ¥
Zheshang Fund Management Co., Ltd.
0.0211 %
5,419 0.0211 % 19 031 ¥

Company contact information

Shandong Keyuan Pharmaceutical Co., Ltd.

Keyuan Street Shandong Shanghe Economic

251601, Jinan

+

http://www.keyuanpharma.com
address Shandong Keyuan Pharmaceutical Co., Ltd.(301281)

Sector

Healthcare
Pharmaceuticals & Medical Research
Pharmaceuticals
Pharmaceuticals
Other Pharmaceuticals

Sales per Business

Sales per region

Sector Other Pharmaceuticals

1st Jan change Capi.
SHANDONG KEYUAN PHARMACEUTICAL CO., LTD. Stock Shandong Keyuan Pharmaceutical Co., Ltd.
-29.49% 358M
ELI LILLY AND COMPANY Stock Eli Lilly and Company
+51.63% 796B
NOVO NORDISK A/S Stock Novo Nordisk A/S
+41.51% 628B
JOHNSON & JOHNSON Stock Johnson & Johnson
-5.10% 358B
MERCK & CO., INC. Stock Merck & Co., Inc.
+19.90% 331B
ABBVIE INC. Stock AbbVie Inc.
+9.95% 301B
ASTRAZENECA PLC Stock AstraZeneca PLC
+17.66% 244B
ROCHE HOLDING AG Stock Roche Holding AG
+3.39% 228B
NOVARTIS AG Stock Novartis AG
+10.75% 214B
AMGEN INC. Stock Amgen Inc.
+6.99% 165B
Other Pharmaceuticals
  1. Stock Market
  2. Equities
  3. 301281 Stock
  4. Company Shandong Keyuan Pharmaceutical Co., Ltd.